Veeva Shares Advance on Revenue, AI Growth

VEEV offers cloud computing products and services for life sciences work with specific functionality and regulatory compliance built in. From managing customers to sales to organizational data, VEEV offers its pharmaceutical and other clients to benefit from modern IT solutions while also adhering to industry standards and requirements. The company is successfully integrating AI into its products, with adoption picking up with larger clients and plans to migrate AI to all clients in the future.

As for earnings, VEEV’s fourth-quarter fiscal 2025 earnings report showed quarterly revenue of $721 million and full-year revenue of nearly $2.8 billion, both of which exceeded expectations. The company also announced a goal of $6 billion in revenue by 2030, reflecting significant expansion plans. While macroeconomic challenges could slow growth, the company’s increased engagement with big pharma companies has resulted in the adoption of its full clinical platform.

It’s no wonder VEEV shares are up 8% this year – and they could rise more. MAPsignals data shows how Big Money investors are betting heavily on the forward picture of the stock.

Big Money Buying Veeva

Institutional volumes reveal plenty. Recently, VEEV has enjoyed strong investor demand, which we believe to be institutional support.

Each green bar signals unusually large volumes in VEEV shares. They reflect our proprietary inflow signal, pushing the stock higher:

Plenty of health care names are under accumulation right now. But there’s a powerful fundamental story happening with Veeva.

Veeva Fundamental Analysis

Institutional support and a healthy fundamental backdrop make this company worth investigating. As you can see, VEEV has had strong sales and earnings growth:

• 3-year sales growth rate (+14.1%)
• 3-year EPS growth rate (+17.2%)

Source: FactSet

Also, EPS is estimated to ramp higher this year by +10.9%.

Now it makes sense why the stock has been powering to new heights. VEEV has a track record of strong financial performance.

Marrying great fundamentals with our proprietary software has found some big winning stocks over the long term.

Veeva has been a top-rated stock at MAPsignals for years. That means the stock has unusual buy pressure and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis.

It’s made the rare Top 20 report multiple times in the past couple years. The blue bars below show when VEEV was a top pick…climbing higher with time:

Tracking unusual volumes reveals the power of money flows.

This is a trait that most outlier stocks exhibit…the best of the best. Big Money demand drives stocks upward.

Veeva Price Prediction

The VEEV rally isn’t new at all. Big Money buying in the shares is signaling to take notice. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a diversified portfolio.

Disclosure: the author holds no position in VEEV at the time of publication.

If you are a Registered Investment Advisor (RIA) or are a serious investor, take your investing to the next level, learn more about the MAPsignals process here.